Table 1 Demographic and clinical characteristics
Variable | Sample(n = 259) | % |
|---|---|---|
 Age (median) | 60 | 50–67 (IQR) |
 Male gender | 140 | 54.1 |
Education level | ||
 Primary school | 8 | 3.1 |
 Secondary education | 74 | 28.6 |
 Secondary vocational | 68 | 26.3 |
 Bachelor | 75 | 29 |
 Master | 25 | 9.7 |
 Living alone | 50 | 19.3 |
 Living with family/roommates | 209 | 80.7 |
Work situation | ||
 Unemployed | 55 | 21.2 |
 Employed | 70 | 27 |
 Receive sickness benefit | 51 | 19.7 |
 Retired | 81 | 31.3 |
Diagnosis | ||
 Acute leukemia | 69 | 26.6 |
 Chronic leukemia* | 57 | 22 |
 (Non)hodgkin* | 39 | 15.1 |
 Multiple myeloma* | 73 | 28.2 |
 Others | 21 | 8.1 |
 Smoking | 15 | 5.8 |
 Alcohol consumption (daily) | 56 | 21.6 |
Medication | ||
 Anti-cancer medication | 101 | 40.9 |
 Growth factor | 16 | 6.5 |
 Bisphosphonates | 51 | 20.6 |
 Anticoagulants | 45 | 18.2 |
 Antibiotics | 138 | 55.9 |
 Corticosteroids | 86 | 34.8 |
 Immunosuppressants | 46 | 18.6 |
HADS | ||
 Anxiety >8 | 55 | 22.3 |
 Depression >8 | 52 | 21,1 |
ICQ | ||
 Helplessness (median) | 12 | 9–16 (IQR) |
 Acceptance (median) | 17 | 14–20 (IQR) |
 Disease benefits (median) | 16 | 12–19 (IQR) |
EORTC-QLQ30 | ||
 Global health (median) | 66.7 | 58.3–83.3(IQR) |
 Physical function (median) | 80 | 60–93.3(IQR) |
 Role function (median) | 66.6 | 33.3–100 (IQR) |
 Emotional function (median) | 83.3 | 66.7–100 (IQR) |
 Cognitive function (median) | 83.3 | 36.7–100 (IQR) |
 Social function (median) | 83.3 | 66.7–100 (IQR) |
 Fatigue (median) | 33.3 | 22.2–55.6(IQR) |
 Nausea (median) | 0 | 0–16.7 (IQR) |
 Pain (median) | 16.7 | 0–33.3 (IQR) |
 Dyspnea (median) | 33.3 | 0–33.3 (IQR) |
 Insomnia (median) | 33.3 | 0–33.3 (IQR) |
 Loss of appetite (median) | 0 | 0–33.3 (IQR) |
 Constipation (median) | 0 | 0–8.33 (IQR) |
 Diarrhea (median) | 0 | 0–0 (IQR) |
 Financial problems (median) | 0 | 0–33.3 (IQR) |
BMQ | ||
 Necessity (median) | 19 | 16–23 (IQR) |
 Concerns (median) | 16 | 13–20 (IQR) |